Why GlaxoSmithKline plc And Vertu Motors Plc Look Like Star Buys

These 2 stocks appear to be worth buying right now: GlaxoSmithKline plc (LON: GSK) and Vertu Motors Plc (LON: VTU)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While the results of companies can sometimes disappoint, it often takes them less time than expected to turn their performance around. As such, there are often opportunities for investors to benefit from investing in stocks that may not be among the most popular at the present time, but which have the potential to become firm investor favourites over the medium to long term.

For example, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) remains a relatively unpopular stock among investors. Evidence of this can be seen in the company’s share price performance, with GlaxoSmithKline’s valuation having fallen by 11% in the last year as investor sentiment has remained weak due to disappointing sales and profit performance, as well as concerns regarding bribery allegations in the company’s recent past.

However, looking ahead, GlaxoSmithKline is likely to deliver significantly improved performance. For example, its sales are forecast to be 8% higher in 2016 than they were in 2014, with the company’s bottom line expected to rise by as much as 6% next year. Certainly, this growth rate may still be behind a number of the company’s peers, but with an excellent pipeline of drugs that is well-diversified and includes the significant potential of the ViiV Health Care division’s HIV treatments, GlaxoSmithKline could be on the cusp of a very different era of financial performance.

Passive income stocks: our picks

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

Furthermore, concerns regarding the wider economy are unlikely to significantly hurt GlaxoSmithKline’s performance. For example, worries about the impact of interest rate rises on the US and UK economies are unlikely to affect GlaxoSmithKline due to its relatively low correlation with the wider macroeconomic outlook. And, while GlaxoSmithKline has a beta of 1, its shares are likely to be less volatile than those of its index peers due to its lack of cyclicality, which may appeal to investors over the medium to long term.

Meanwhile, despite automotive dealership operator, Vertu Motors (LSE: VTU), having seen its share price rise by 120% in the last five years, it still trades on a relatively low valuation. In fact, Vertu Motors has a price to earnings (P/E) ratio of only 11.7 despite the outlook for the global automotive industry being relatively positive and the company itself being forecast to increase its earnings by 5% in the current year, and by a further 11% next year.

In fact, these forecast growth numbers put Vertu Motors on a price to earnings growth (PEG) ratio of just 1, which indicates that its share price could move significantly higher. And, while it currently yields just 1.7%, Vertu Motors has a rather low payout ratio of 20% which, when combined with its strong earnings outlook, means that impressive dividend growth prospects are likely to be ahead over the medium to long term. As a result, its shares could continue their upward trajectory – especially since the next five years are likely to be more prosperous than the last five for the global economy.

5 stocks for trying to build wealth after 50

Inflation recently hit 40-year highs… the ‘cost of living crisis’ rumbles on… the prospect of a new Cold War with Russia and China looms large, while the global economy could be teetering on the brink of recession.

Whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times. Yet despite the stock market’s recent gains, we think many shares still trade at a discount to their true value.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. We believe these stocks could be a great fit for any well-diversified portfolio with the goal of building wealth in your 50’s.

Claim your free copy now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline and Vertu Motors. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

After collapsing 28% today, are Bunzl shares too cheap to ignore?

A poor trading statement has sent Bunzl shares to multi-year lows. Could now be a good time to consider investing…

Read more »

Investing Articles

These 5 stocks could earn £1,600 of annual passive income in a £20,000 ISA

Harvey Jones shows how to generate a high and rising passive income by buying a balanced mix of high-yielding FTSE…

Read more »

Young woman holding up three fingers
Investing Articles

3 things I like about Greggs shares

Greggs shares have tumbled by more than a third over the past year. But this writer has no plan to…

Read more »

artificial intelligence investing algorithms
Investing Articles

Nvidia stock: beware the bear market rally

Andrew Mackie argues that investors should tread carefully before investing in Nvidia stock, as the worst of the sell-off could…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

Up 73% in one year, is this the best value stock in the FTSE 100?

A brilliant run of form suggests this FTSE 100 giant should no longer make the cut as a value stock.…

Read more »

Investing Articles

The best could yet be to come for UK shares! I’m buying these ones

Amid ongoing stock market turbulence, this writer's been adding selected UK shares to his portfolio. Here's why and what he…

Read more »

Top Stocks

4 UK stocks trading well below book value to consider buying

Sometimes, it pays to be contrarian: who says the UK market has priced a stock precisely right, anyway?

Read more »

Investing Articles

The S&P 500’s 12% off its highs. Is now a good time to buy US shares for an ISA?

Right now, a lot of British investors are wondering whether it’s a good time to buy US shares. Here, Edward…

Read more »